Trade Name: Portrazza
Necitumumab is the generic name for the trade name drug Portrazza.
In some cases, health care professionals may use the trade name Portrazza when referring to the generic drug name necitumumab.
Drug type: Necitumumab is classified as a "monoclonal antibody" and "signal transduction inhibitor" by binding to epidermal growth factor receptors (EGFR). (For more detail, see "How Necitumumab Works" section below).
What Necitumumab Is Used For :
Note: If a drug has been approved for one use, physicians may elect to use this same drug for other problems if they believe it may be helpful.
How Necitumumab Is Given :